+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Xenograft"

Regenerative Xenograft Market Report 2026 - Product Thumbnail Image

Regenerative Xenograft Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Spatial Multiomics Market - Global Forecast to 2036 - Product Thumbnail Image

Spatial Multiomics Market - Global Forecast to 2036

  • Report
  • September 2026
  • 547 Pages
  • Global
From
Preclinical CRO Market - Global Forecast 2026-2032 - Product Thumbnail Image

Preclinical CRO Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 196 Pages
  • Global
From
Drug Discovery Technologies Market - Global Forecast 2026-2032 - Product Thumbnail Image

Drug Discovery Technologies Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
In Vivo CRO Market - Global Forecast 2026-2032 - Product Thumbnail Image

In Vivo CRO Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 183 Pages
  • Global
From
From
From
Experimental Animal Model Market - Global Forecast 2026-2032 - Product Thumbnail Image

Experimental Animal Model Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
From
From
From
From
From
Animal Model Market Report 2026 - Product Thumbnail Image

Animal Model Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator

A xenograft is a type of biotechnology that involves the transplantation of tissue from one species to another. It is commonly used in medical research and in the development of new treatments for diseases. Xenografts are also used in the production of therapeutic proteins, such as antibodies, and in the production of cell-based therapies. The xenograft market is a rapidly growing sector of the biotechnology industry. It is driven by the increasing demand for new treatments for diseases, as well as the need for more efficient and cost-effective production of therapeutic proteins and cell-based therapies. The market is also driven by advances in technology, such as gene editing and stem cell research, which have enabled the development of more sophisticated xenografts. Some of the major companies in the xenograft market include Novartis, Pfizer, Merck, and Amgen. These companies are involved in the development and production of xenografts for medical research and therapeutic applications. Other companies in the market include AbbVie, AstraZeneca, and Regeneron. Show Less Read more